U.S. markets open in 5 hours 59 minutes
  • S&P Futures

    4,368.50
    +25.25 (+0.58%)
     
  • Dow Futures

    34,008.00
    +210.00 (+0.62%)
     
  • Nasdaq Futures

    15,084.25
    +60.25 (+0.40%)
     
  • Russell 2000 Futures

    2,197.50
    +16.60 (+0.76%)
     
  • Crude Oil

    70.51
    -0.05 (-0.07%)
     
  • Gold

    1,778.90
    +0.70 (+0.04%)
     
  • Silver

    22.79
    +0.18 (+0.79%)
     
  • EUR/USD

    1.1736
    +0.0006 (+0.05%)
     
  • 10-Yr Bond

    1.3240
    0.0000 (0.00%)
     
  • Vix

    22.71
    -3.00 (-11.67%)
     
  • GBP/USD

    1.3649
    -0.0015 (-0.11%)
     
  • USD/JPY

    109.4590
    +0.2390 (+0.22%)
     
  • BTC-USD

    42,272.64
    -675.98 (-1.57%)
     
  • CMC Crypto 200

    1,052.01
    -11.84 (-1.11%)
     
  • FTSE 100

    7,055.80
    +74.82 (+1.07%)
     
  • Nikkei 225

    29,639.40
    -200.31 (-0.67%)
     

Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

ST. LOUIS, July 20, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2021 second quarter on Tuesday, August 10, 2021 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments.

What:

Stereotaxis second quarter 2021 financial results conference call

When:

Tuesday, August 10, 2021 at 10:00 a.m. EST (7:00 a.m. PST)

Dial In Number:

To access the live call, dial 800-437-2398 (US and Canada) or 856-344-9206 (International) and give the participant pass code 8321875.

Webcast:

To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/

Call Replay:

A phone replay of the call will be available for one month beginning approximately two hours following the end of the call. To request access for a replay of the conference call, please Click Here.

About Stereotaxis

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere. For more information, please visit www.stereotaxis.com.

Company Contacts:
David L. Fischel
Chairman and Chief Executive Officer

Kimberly Peery
Chief Financial Officer

314-678-6100
investors@stereotaxis.com